ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. The great quarter was driven by high ...

ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst ...

(RTTNews) - Resmed Inc (RMD) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The company's earnings totaled $344.6 million, or $2.34 per share.

NEW YORK, January 29, 2025--(BUSINESS WIRE)--Atrium, a leading Global Extended Workforce Management and Talent Solutions provider, is excited to partner with the NFL Player Care Foundation (PCF ...

The high price of automobiles is one of the greatest banes in the consumer, commuter existence. We’re always wondering, “Will cars get cheaper?” In a recent post on his YouTube channel ...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future growth opportunities. The ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

The transcatheter device uses a short pulse of energy to create a durable passage between the left and right atrium. It aims to reduce excess pressure within the left atrium through a less ...

"Part man. Part dog. All hero." ...